High-grade gold, copper, silver and tungsten assay results have been received for a further five holes from its ongoing drilling program designed to outline...
Rigel and Vega confirmed as a major caesium discovery with potential to be a significant supply source for global markets, including the next wave of terrestrial solar technologies
MONTREAL ,...
Rigel and Vega confirmed as a major caesium discovery with potential to be a significant supply source for global markets, including the next wave of terrestrial solar technologies
MONTREAL,...
Rigel and Vega confirmed as a major caesium discovery with potential to be a significant supply source for global markets, including the next wave of terrestrial solar technologies
MONTREAL ,...
Intersects Ginguro-Banded Quartz Veins
OTTAWA, ON, July 18, 2025 /CNW/ - Northern Shield Resources Inc. ("Northern Shield" or the "Company") (TSXV: NRN) is pleased to...
NetworkNewsWire Editorial Coverage
NEW YORK, July 17, 2025 /PRNewswire/ -- For years, the mining industry has revolved around high-risk, capital-intensive exploration, where the odds of...
NetworkNewsWire Editorial Coverage
NEW YORK, July 17, 2025 /CNW/ -- For years, the mining industry has revolved around high-risk, capital-intensive exploration, where the odds of...
NetworkNewsWire Editorial Coverage
NEW YORK, July 17, 2025 /PRNewswire/ -- For years, the mining industry has revolved around high-risk, capital-intensive exploration, where the odds of...
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3...
"Highlighting Strategic Alliances and Innovation, the Global GPCR Targeting Market Report Explores the Role of GPCRs in Drug Discovery and Therapeutics, Featuring Key Players...
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.
TORONTO, July 16, 2025 /CNW/ - Denison Mines Corp. ("Denison" or the "Company") (TSX: DML) (NYSE American: DNN) is pleased to announce the discovery of additional...
VANCOUVER, BC, July 16, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to report results...
VANCOUVER, BC, July 16, 2025 /CNW/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to report results...